Pacific Biosciences of California, Inc. Proceeds from Sale of Debt Securities, Available-for-sale
Pacific Biosciences of California, Inc. (PACB) reported Proceeds from Sale of Debt Securities, Available-for-sale of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt · last filed 2026-02-25
- Pacific Biosciences of California, Inc. proceeds from sale of debt securities, available-for-sale for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Pacific Biosciences of California, Inc. proceeds from sale of debt securities, available-for-sale for the quarter ending 2024-12-31 was $26.80M.
- Pacific Biosciences of California, Inc. proceeds from sale of debt securities, available-for-sale for the quarter ending 2024-09-30 was $8.06M.
- Pacific Biosciences of California, Inc. proceeds from sale of debt securities, available-for-sale for the quarter ending 2024-06-30 was $0.00.
- Pacific Biosciences of California, Inc. proceeds from sale of debt securities, available-for-sale for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. proceeds from sale of debt securities, available-for-sale for fiscal 2024 was $34.86M, a 5758.15% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. proceeds from sale of debt securities, available-for-sale for fiscal 2023 was $595.00K.
- Pacific Biosciences of California, Inc. proceeds from sale of debt securities, available-for-sale for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from Sale of Debt Securities, Available-for-sale 3 month | Proceeds from Sale of Debt Securities, Available-for-sale 6 month | Proceeds from Sale of Debt Securities, Available-for-sale 9 month | Proceeds from Sale of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | |||
| 2024-12-31 | $26.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $34.86M derived: sum of 2 quarters · filed 2026-02-25 | $34.86M derived: sum of 3 quarters · filed 2026-02-25 | $34.86M 10-K · filed 2026-02-25 |
| 2024-09-30 | $8.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.06M derived: sum of 2 quarters · filed 2025-11-06 | $8.06M 10-Q · filed 2025-11-06 | $8.06M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $595.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $595.00K 10-Q · filed 2024-11-12 | $595.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $595.00K 10-Q · filed 2024-08-09 | $595.00K derived: sum of 3 quarters · filed 2025-03-17 | $595.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $595.00K 10-Q · filed 2024-05-09 | $595.00K derived: sum of 2 quarters · filed 2025-03-17 | $595.00K derived: sum of 3 quarters · filed 2025-03-17 | $595.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $0.00 derived: sum of 3 quarters · filed 2025-03-17 | $0.00 10-K · filed 2025-03-17 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $178.18M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $178.18M derived: sum of 3 quarters · filed 2024-02-28 | $208.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $178.18M derived: sum of 2 quarters · filed 2024-02-28 | $208.14M derived: sum of 3 quarters · filed 2024-02-28 | $212.73M 10-K · filed 2024-02-28 |
| 2021-09-30 | $178.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $208.14M derived: sum of 2 quarters · filed 2022-11-08 | $212.73M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $29.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $34.56M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $4.60M 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $1.40M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $1.50M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |